Holen Sie sich die Stockscreener-App
4.84
2.81%
-0.14
Handel nachbörslich:
5.06
0.22
+4.55%
Schlusskurs vom Vortag:
$4.98
Offen:
$5.04
24-Stunden-Volumen:
138.46K
Relative Volume:
1.26
Marktkapitalisierung:
$84.87M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-24.05M
KGV:
-2.2512
EPS:
-2.15
Netto-Cashflow:
$-17.78M
1W Leistung:
+17.33%
1M Leistung:
+19.51%
6M Leistung:
+37.50%
1J Leistung:
-15.09%
1-Tages-Spanne:
$4.72
$5.04
1-Wochen-Bereich:
$4.1515
$5.62
52-Wochen-Spanne:
$2.0278
$5.915
Envveno Medical Corporation Stock (NVNO) Company Profile
Firmenname
Envveno Medical Corporation
Sektor
Branche
Telefon
949-261-2900
Adresse
70 DOPPLER, IRVINE
Vergleichen Sie NVNO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
4.84 | 72.34M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Envveno Medical Corporation Aktie (NVNO) Neueste Nachrichten
What analysts say about enVVeno Medical Corporation stockOutstanding growth strategies - Autocar Professional
Is enVVeno Medical Corporation a good long term investmentBreakout portfolio performance - jammulinksnews.com
enVVeno Medical Corporation Stock Analysis and ForecastRemarkable growth - jammulinksnews.com
enVVeno Medical Participates in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference - IndyStar
iTolerance, Inc. Participates in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference - Bergen Record
Inside enVVeno Medical: CEO Shares Breakthrough Vision for Deep Venous Disease Treatment Revolution - Stock Titan
What makes enVVeno Medical Corporation stock price move sharplyReal Trader Insights - Newser
What drives enVVeno Medical Corporation stock priceAccelerated earnings growth - Autocar Professional
JTC Team Announces Participating Line Up for the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference - Pocono Record
Companies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In Growth - simplywall.st
How enVVeno Medical Corporation stock performs during market volatilityHigh Reward Risk Balanced Trading - Newser
Why enVVeno Medical Corporation stock attracts strong analyst attentionLow Risk Profit Ideas - Newser
Envoy Medical and enVVeno: Navigating Near-Term Turbulence for Long-Term Medical Device Dominance - AInvest
Jane Street Group LLC Acquires New Shares in enVVeno Medical Corporation (NASDAQ:NVNO) - Defense World
enVVeno Medical (NVNO) Shares Update on Promising Two-Year VenoV - GuruFocus
Positive Interim 2-Year Data from enVVeno Medical's VenoValve Pivotal Study to be Presented Today at the Society for Vascular Surgery (SVS) 2025 Vascular Annual Meeting - The Oklahoman
enVVeno Medical (NVNO) Showcases Promising Two-Year Data for Ven - GuruFocus
enVVeno Medical (NVNO) Shares Update on Promising Two-Year VenoValve Trial Results | NVNO Stock News - GuruFocus
Positive Interim 2-Year Data from enVVeno Medical's VenoValve Pi - GuruFocus
enVVeno Medical announces two-year data from VenoValve pivotal study - TipRanks
enVVeno Medical announces interim two-year follow-up data on VenoValve trial - TipRanks
Positive Interim 2-Year Data from enVVeno Medical's VenoValve Pivotal Study to be Presented Today at the Society for Vascular Surgery (SVS) 2025 Vascular Annual Meeting | NVNO Stock News - GuruFocus
VenoValve Shows 83% Success Rate in 2-Year Trial Data, FDA Decision Due 2025 | NVNO Stock News - Stock Titan
enVVeno Medical Corporation (NASDAQ:NVNO) Short Interest Up 19.4% in May - Defense World
NVNBWForm FWPFiling under Securities Act Rules 163/433 of free writing prospectuses - mx.advfn.com
Northern Trust Corp Raises Holdings in enVVeno Medical Corporation (NASDAQ:NVNO) - Defense World
enVVeno Medical surges 70% following InvestingPro’s Fair Value signal By Investing.com - Investing.com India
enVVeno Medical appoints Jennifer Bright as financial chief - MSN
enVVeno Medical Appoints New Chief Financial Officer - TipRanks
enVVeno Medical Appoints Jennifer Bright as Chief Financial Officer - BioSpace
enVVeno Medical appoints new CFO amid growth phase By Investing.com - Investing.com South Africa
Finanzdaten der Envveno Medical Corporation-Aktie (NVNO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.64%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):